The results of our study may indicate that MMP-2 inhibition is therapeutically applicable during development of hypertension, while in developed, stabilized and uncomplicated hypertension, systemic MMP-2 and MMP-9 inhibition may not be desirable. This evidence concerns the gene MMP2 and Hypertension.